Form D · Hedge Fund
Essex Global Life Sciences Fund, LP
Boston, MA · CIK 0001505786
Offering snapshot reported Feb 11, 2016 · SEC filing
- Reported sold
- $4.74M Indefinite offering
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $500K Reported outside-investor minimum
- First sale
- Apr 8, 1998 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$4,088,957 → $4,738,957
- Reported investors5 → 7
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 11, 2016 | Amendment | $4,738,957 | $650,000vs Nov 21, 2014 | 7 | SEC filing |
| Nov 21, 2014 | Amendment | $4,088,957 | $100,000vs Nov 26, 2013 | 5 | SEC filing |
| Nov 26, 2013 | Amendment | $3,988,957 | $0vs Nov 2, 2012 | 4 | SEC filing |
| Nov 4, 2013 | Initial | $3,988,957 | No comparison | 4 | SEC filing |
| Nov 2, 2012 | Amendment | $3,988,957 | $22,000vs Oct 20, 2011 | 4 | SEC filing |
| Oct 20, 2011 | Amendment | $3,966,957 | $2,603,491vs Nov 17, 2010 | 4 | SEC filing |
| Nov 17, 2010 | Amendment | $1,363,466 | -$1,403,534vs Nov 16, 2010 | 4 | SEC filing |
| Nov 16, 2010 | Initial | $2,767,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-150594
Source: Form D, filed Feb 11, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
ESSEX GLOBAL LIFE SCIENCES FUND, LP
Investment adviser: ESSEX INVESTMENT MANAGEMENT COMPANY, LLC
- Gross asset value
- $16.7M
- Beneficial owners
- 5
- ADV minimum commitment
- $500K
Reported in Form ADV on Dec 16, 2019. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
Provider details
- Annual audit
- Yes
- Prime brokers
- Yes
- Custodians
- Yes
- Administrator other than the adviser
- Yes
- External marketing
- Yes
WITHUM SMITH+BROWN, PC
PCAOB 100
MORGAN STANLEY & CO. LLC
SEC 8-15869
HAMERSLEY PARTNERS LLC
CRD 131134 · SEC 8-66427
MORGAN STANLEY & CO. LLC
CRD 8209 · SEC 8-15869
Filing source
Form ADV 1362666 · Dec 16, 2019 · Schedule D 7.B.(1), fund 805-2755250625
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stephen R. Clark | Executive |
| Luis Cortez | Executive |
| Martin Cournan | Executive |
| Stephen D. Cutler | Executive |
| Essex Investment Management Company, Llc | Promoter |
| N/A N/A Essex Investment Managment Company, Llc | Executive, Promoter |
| Alexander Forse | Executive |
| Elizabeth Giroux | Executive |
| Michael Mc Carthy | Executive |
| Christopher P. Mc Connell | Executive |
| Anne Marie Mc Michael | Executive |
| Joseph Mc Nay | Executive |
| William Page | Executive |
| Nancy Prial | Executive |
| Saralyn Sacks | Executive |
| Robert Uek | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:Boston, MA, 02110